Risk-association of five SNPs in TOX3/LOC643714 with breast cancer in southern China

International Journal of Molecular Sciences

Volumn 15, Issue 2, 2014, Pages 2130-2141

  He, Xuanqiu ^a   Yao, Guangyu ^a   Li, Fenxia ^a   Li, Ming ^a   Yang, Xuexi ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Single nucleotide polymorphism (SNP); Susceptibility; TOX3 LOC643714

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TNRC9 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DNA MODIFICATION; FEMALE; GENE; GENE EXPRESSION; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HISTOLOGY; HUMAN; HUMAN TISSUE; LOC 643714; MAJOR CLINICAL STUDY; MEDULLARY CARCINOMA; POLYMERASE CHAIN REACTION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TOX GENE; ALLELE; BREAST TUMOR; CANCER STAGING; CHINA; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; RISK; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; BREAST NEOPLASMS; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; MIDDLE AGED; NEOPLASM STAGING; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; YOUNG ADULT;

EID: 84893170144     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15022130     Document Type: Article

References (33)

1. Ferlay, J.; Shin, H.R.; Bray, F.; Forman, D.; Mathers, C.; Parkin, D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 2010, 127, 2893-2917.
2. Yang, L.; Parkin, D.M.; Li, L.D.; Chen, Y.D.; Bray, F. Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br. J. Cancer 2004, 90, 2157-2166.
3. Dapic, V.; Carvalho, M.A.; Monteiro, A.N. Breast cancer susceptibility and the DNA damage response. Cancer Control 2005, 12, 127-136.
4. Walsh, T.; King, M.C. Ten genes for inherited breast cancer. Cancer Cell 2007, 11, 103-105.
5. Pharoah, P.D.; Dunning, A.M.; Ponder, B.A.; Easton, D.F. Association studies for finding cancer-susceptibility genetic variants. Nat. Rev. Cancer 2004, 4, 850-860.
6. Easton, D.F.; Pooley, K.A.; Dunning, A.M.; Pharoah, P.D.; Thompson, D.; Ballinger, D.G.; Struewing, J.P.; Morrison, J.; Field, H.; Luben, R. et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007, 447, 1087-1093.
7. Stacey, S.N.; Manolescu, A.; Sulem, P.; Rafnar, T.; Gudmundsson, J.; Gudjonsson, S.A.; Masson, G.; Jakobsdottir, M.; Thorlacius, S.; Helgason, A. et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat. Genet. 2007, 39, 865-869.
8. Hunter, D.J.; Kraft, P.; Jacobs, K.B.; Cox, D.G.; Yeager, M.; Hankinson, S.E.; Wacholder, S.; Wang, Z.; Welch, R.; Hutchinson, A. et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat. Genet. 2007, 39, 870-874.
9. Cox, A.; Dunning, A.M.; Garcia-Closas, M.; Balasubramanian, S.; Reed, M.W.; Pooley, K.A.; Scollen, S.; Baynes, C.; Ponder, B.A.; Chanock, S. et al. A common coding variant in CASP8 is associated with breast cancer risk. Nat. Genet. 2007, 39, 352-358.
10. Thomas, G.; Jacobs, K.B.; Kraft, P.; Yeager, M.; Wacholder, S.; Cox, D.G.; Hankinson, S.E.; Hutchinson, A.; Wang, Z.; Yu, K. et al. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat. Genet. 2009, 41, 579-584.
11. Reeves, G.K.; Travis, R.C.; Green, J.; Bull, D.; Tipper, S.; Baker, K.; Beral, V.; Peto, R.; Bell, J.; Zelenika, D. et al. Incidence of breast cancer and its subtypes in relation to individual and multiple low-penetrance genetic susceptibility loci. JAMA 2010, 304, 426-434.
12. Ruiz-Narvaez, E.A.; Rosenberg, L.; Cozier, Y.C.; Cupples, L.A.; Adams-Campbell, L.L.; Palmer, J.R. Polymorphisms in the TOX3/LOC643714 locus and risk of breast cancer in African-American women. Cancer Epidemiol. Biomark. Prev. 2010, 19, 1320-1327.
13. Long, J.; Shu, X.O.; Cai, Q.; Gao, Y.T.; Zheng, Y.; Li, G.; Li, C.; Gu, K.; Wen, W.; Xiang, Y.B. et al. Evaluation of breast cancer susceptibility loci in Chinese women. Cancer Epidemiol. Biomark. Prev. 2010, 19, 2357-2365.
14. Zheng, W.; Long, J.; Gao, Y.T.; Li, C.; Zheng, Y.; Xiang, Y.B.; Wen, W.; Levy, S.; Deming, S.L.; Haines, J.L. et al. Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat. Genet. 2009, 41, 324-328.
15. Zheng, W.; Wen, W.; Gao, Y.T.; Shyr, Y.; Zheng, Y.; Long, J.; Li, G.; Li, C.; Gu, K.; Cai, Q. et al. Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women. J. Natl. Cancer Inst. 2010, 102, 972-981.
16. Greenman, C.; Stephens, P.; Smith, R.; Dalgliesh, G.L.; Hunter, C.; Bignell, G.; Davies, H.; Teague, J.; Butler, A.; Stevens, C. et al. Patterns of somatic mutation in human cancer genomes. Nature 2007, 446, 153-158.
17. Yuan, S.H.; Qiu, Z.; Ghosh, A. TOX3 regulates calcium-dependent transcription in neurons. Proc. Natl. Acad. Sci. USA 2009, 106, 2909-2914.
18. Smid, M.; Wang, Y.; Klijn, J.G.; Sieuwerts, A.M.; Zhang, Y.; Atkins, D.; Martens, J.W.; Foekens, J.A. Genes associated with breast cancer metastatic to bone. J. Clin. Oncol. 2006, 24, 2261-2267.
19. Long, J.; Cai, Q.; Shu, X.O.; Qu, S.; Li, C.; Zheng, Y.; Gu, K.; Wang, W.; Xiang, Y.B.; Cheng, J. et al. Identification of a functional genetic variant at 16q12.1 for breast cancer risk: Results from the Asia Breast Cancer Consortium. PLoS Genet. 2010, 6, e1001002.
20. Udler, M.S.; Ahmed, S.; Healey, C.S.; Meyer, K.; Struewing, J.; Maranian, M.; Kwon, E.M.; Zhang, J.; Tyrer, J.; Karlins, E. et al. Fine scale mapping of the breast cancer 16q12 locus. Hum. Mol. Genet. 2010, 19, 2507-2515.
21. National center for biotechnology information. Available online: http://www.ncbi.nlm.nih.gov/gene/643714 (accessed on 7 January 2014).
22. Travers, A.A. Priming the nucleosome: A role for HMGB proteins? EMBO Rep. 2003, 4, 131-136.
23. Dittmer, S.; Kovacs, Z.; Yuan, S.H.; Siszler, G.; Kogl, M.; Summer, H.; Geerts, A.; Golz, S.; Shioda, T.; Methner, A. TOX3 is a neuronal survival factor that induces transcription depending on the presence of CITED1 or phosphorylated CREB in the transcriptionally active complex. J. Cell Sci. 2011, 124, 252-260.
24. Yahata, T.; Shao, W.; Endoh, H.; Hur, J.; Coser, K.R.; Sun, H.; Ueda, Y.; Kato, S.; Isselbacher, K.J.; Brown, M. et al. Selective coactivation of estrogen-dependent transcription by CITED1 CBP/p300-binding protein. Genes Dev. 2001, 15, 2598-2612.
25. Shioda, T.; Lechleider, R.J.; Dunwoodie, S.L.; Li, H.; Yahata, T.; de Caestecker, M.P.; Fenner, M.H.; Roberts, A.B.; Isselbacher, K.J. Transcriptional activating activity of Smad4: Roles of SMAD hetero-oligomerization and enhancement by an associating transactivator. Proc. Natl. Acad. Sci. USA 1998, 95, 9785-9790.
26. Kim, H.C.; Lee, J.Y.; Sung, H.; Choi, J.Y.; Park, S.K.; Lee, K.M.; Kim, Y.J.; Go, M.J.; Li, L.; Cho, Y.S. et al. A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: Results from the Seoul Breast Cancer Study. Breast Cancer Res. 2012, 14, R56.
27. Sueta, A.; Ito, H.; Kawase, T.; Hirose, K.; Hosono, S.; Yatabe, Y.; Tajima, K.; Tanaka, H.; Iwata, H.; Iwase, H. et al. A genetic risk predictor for breast cancer using a combination of low-penetrance polymorphisms in a Japanese population. Breast Cancer Res. Treat. 2012, 132, 711-721.
28. Garcia-Closas, M.; Hall, P.; Nevanlinna, H.; Pooley, K.; Morrison, J.; Richesson, D.A.; Bojesen, S.E.; Nordestgaard, B.G.; Axelsson, C.K.; Arias, J.I. et al. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet. 2008, 4, e1000054.
29. Li, L.; Zhou, X.; Huang, Z.; Liu, Z.; Song, M.; Guo, Z. TNRC9/LOC643714 polymorphisms are not associated with breast cancer risk in Chinese women. Eur. J. Cancer Prev. 2009, 18, 285-290.
30. Liang, J.; Chen, P.; Hu, Z.; Shen, H.; Wang, F.; Chen, L.; Li, M.; Tang, J.; Wang, H. Genetic variants in trinucleotide repeat-containing 9 (TNRC9) are associated with risk of estrogen receptor positive breast cancer in a Chinese population. Breast Cancer Res. Treat. 2010, 124, 237-241.
31. Rinella, E.S.; Shao, Y.; Yackowski, L.; Pramanik, S.; Oratz, R.; Schnabel, F.; Guha, S.; Leduc, C.; Campbell, C.L.; Klugman, S.D. et al. Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation. Hum. Genet. 2013, 132, 523-536.
32. Cowper-Sal lari, R.; Zhang, X.; Wright, J.B.; Bailey, S.D.; Cole, M.D.; Eeckhoute, J.; Moore, J.H.; Lupien, M. Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression. Nat. Genet. 2012, 44, 1191-1198.
33. Sole, X.; Guino, E.; Valls, J.; Iniesta, R.; Moreno, V. SNPStats: A web tool for the analysis of association studies. Bioinformatics 2006, 22, 1928-1929.